Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

29/06/2022 14:30

Jaguar Health Enters Exclusive Crofelemer License and Commercialization Agreement with SynWorld Technologies for Canalevia for Treatment of Diarrhea in Dogs in China

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

22/06/2022 14:30

Jaguar Health Announces Online Availability of a Presentation on Short Bowel Syndrome (SBS) by Dr. Mohamad Miqdady at Elite Ped-GI Congress in Abu Dhabi

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

21/06/2022 14:30

Jaguar Animal Health Exhibiting at the June 23-25 American College of Veterinary Internal Medicine (ACVIM) Forum as Part of Ongoing Commercial Launch Activities for Canalevia-CA1

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

13/06/2022 14:30

Jaguar Health Announces Publication of Onco'Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

10/06/2022 22:15

Jaguar Health Reports Voting Results from 2022 Annual Meeting of Stockholders

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

10/06/2022 14:30

Jaguar Health to Participate in BIO International Convention (BIO 2022)

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

09/06/2022 14:30

Jaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

25/05/2022 14:30

Jaguar Health Announces Napo Therapeutics' Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

24/05/2022 14:30

Jaguar Health Announces Presentation of an Investigator-initiated Evaluation of Crofelemer for a Severe Congenital Diarrheal Disorder at 2022 Digestive Disease Week

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

23/05/2022 13:00

Jaguar Health Announces Launch of the First U.S. Canine Cancer Registry and Canine Cancer Care Index

Voir tous les communiqués de Jaguar Health, Inc.

1
2
3
4
5
»